Walden Biosciences

Walden Biosciences

Walden Biosciences

Walden Biosciences is a biotechnology company relentlessly focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease.
Founded
2020
Raised
$51M
Follow us
Latest funding
$51,000,000
Venture capital (Series A) - 2020
ARCH Venture Partners UCB Ventures
Team Size
1–10
Employees
$51,000,000 Venture capital (Series A)
WSJ Venture Capital

Walden Biosciences to Fight Kidney Disease With $51 Million Series A